Daniel Levy, MD
Dermatology · Bonney Lake, WANPI 1306067814
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $475,992 of the $540,526 with a category attached, or 88.1%. AbbVie accounts for 99.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $186,226 and has fallen 81.1% since, to $35,187 in 2025. Among dermatology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 769 payments — averaging $702.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$539K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$438
- Revance Therapeutics, Inc.$336
- Smith+Nephew$139
- Dermavant Sciences, Inc.$90
- Lilly USA, LLC$59
- plus $217 from 9 others
What the payments were for
- Consulting fees$11,1622%
- Speaking & faculty fees$475,99288%
- Travel & lodging$43,9568%
- Food & beverage$9,4162%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 701 | $539,247 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 39 | $438 |
| Revance Therapeutics, Inc. | 7 | $336 |
| Smith+Nephew | 2 | $139 |
| Dermavant Sciences, Inc. | 5 | $90 |
| Lilly USA, LLC | 3 | $59 |
| Johnson & Johnson | 3 | $50 |
| UCB, Inc. | 1 | $34 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Sientra, Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Amgen | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Organon | 1 | $9 |
| Next Science LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$217,482
- BOTOX COSMETIC$37,636
- KYBELLA$6,500
How this compares
$540,526 in reported general payments places this provider in the 95th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 11 | $521 |
| Levofloxacin | 12 | $497 |
| Minoxidil | 15 | $160 |
| Ondansetron OdtOndansetron | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bonney Lake
- Clive LiuBellevue$2.9M
- Vivian ShiSeattle$971K
- William WerschlerSpokane$948K
- Daniel SugaiBellevue$302K
- Ting-Lin YangBellingham$124K
- James CollyerSeattle$115K
- Cameron ChesnutSpokane$93K
- Alison YoungSeattle$53K
- Eileen SmithWalla Walla$49K
- Jing LiuBellevue$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.